{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T05:27:42Z","timestamp":1755926862524},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00277-024-05887-6","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T03:28:51Z","timestamp":1720754931000},"page":"3801-3804","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ETV6::ABL1 positive myeloid\/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK) with blast crisis treated with flumatinib mesylate"],"prefix":"10.1007","volume":"103","author":[{"given":"Fei","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"key":"5887_CR1","unstructured":"Brunel V, Sainty D, Carbuccia N et al (1996) A TEL\/ABL fusion gene on chromosome 12p13 in a case of Ph-, BCR- atypical CML. Leukemia 10:2003"},{"issue":"3","key":"5887_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/(SICI)1098-2264(199711)20:3<299::AID-GCC11>3.0.CO;2-K","volume":"20","author":"P Andreasson","year":"1997","unstructured":"Andreasson P, Johansson B, Carlsson M et al (1997) BCR\/ABL-negative chronic myeloid leukemia with ETV6\/ABL fusion. Genes Chromosomes Cancer 20(3):299\u2013304","journal-title":"Genes Chromosomes Cancer"},{"issue":"7","key":"5887_CR3","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/sj.leu.2401091","volume":"12","author":"T Nilsson","year":"1998","unstructured":"Nilsson T, Andreasson P, Hoglund M et al (1998) ETV6\/ABL fusion is rare in Ph-negative chronic myeloid disorders. Leukemia 12(7):1167\u20131168","journal-title":"Leukemia"},{"issue":"3","key":"5887_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/1098-2264(2000)9999:9999<1::AID-GCC1089>3.0.CO;2-1","volume":"30","author":"H Van Limbergen","year":"2001","unstructured":"Van Limbergen H, Beverloo HB, van Drunen E et al (2001) Molecular cytogenetic and clinical findings in ETV6\/ABL1-positive leukemia. Genes Chromosome Cancer 30(3):274\u2013282","journal-title":"Genes Chromosome Cancer"},{"issue":"2","key":"5887_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/sj.leu.2402353","volume":"16","author":"H Lin","year":"2002","unstructured":"Lin H, Guo JQ, Andreeff M et al (2002) Detection of dual TEL-ABL transcripts and a tel-abl protein containing phosphotyrosine in a chronic myeloid leukemia patient. Leukemia 16(2):294\u2013297","journal-title":"Leukemia"},{"issue":"2","key":"5887_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0165-4608(02)00609-X","volume":"138","author":"YK Keung","year":"2002","unstructured":"Keung YK, Beaty M, Steward W et al (2002) Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13), and ETV6-ABL gene rearrangement: case report and review of the literature. Cancer Genet Cytogenet 138(2):139\u2013142","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"5887_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1046\/j.1365-2141.2003.04391.x","volume":"122","author":"A Barbouti","year":"2003","unstructured":"Barbouti A, Ahlgren T, Johansson B et al (2003) Clinical and genetic studies of ETV6\/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate. Br J Haematol 122(1):85\u201393","journal-title":"Br J Haematol"},{"issue":"10","key":"5887_CR8","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/gcc.20593","volume":"47","author":"N Kawamata","year":"2008","unstructured":"Kawamata N, Dashti A, Lu D et al (2008) Chronic phase of ETV6-ABL1 positive CML responds to imatinib. Genes Chromosomes Cancer 47(10):919\u2013921","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"5887_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cancergencyto.2009.02.012","volume":"192","author":"JC Kelly","year":"2009","unstructured":"Kelly JC, Shahbazi N, Scheerle J et al (2009) Insertion (12;9)(p13;q34): a cryptic rearrangement involving ABL1\/ETV6 fusion in a patient with Philadelphia-negative chronic myeloid leukemia. Cancer Genet Cytogenet 192(1):36\u201339","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"5887_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3324\/haematol.2010.036673","volume":"96","author":"F Perna","year":"2011","unstructured":"Perna F, Abdel-Wahab O, Levine RL et al (2011) ETV6-ABL1-positive chronic myeloid leukemia: clinical and molecular response to tyrosine kinase inhibition. Haematologica 96(2):342\u2013343","journal-title":"Haematologica"},{"issue":"1","key":"5887_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3343\/alm.2017.37.1.77","volume":"37","author":"SI Choi","year":"2017","unstructured":"Choi SI, Jang MA, Jeong WJ et al (2017) A case of chronic myeloid leukemia with rare variant ETV6\/ABL1 rearrangement. Ann Lab Med 37(1):77\u201380","journal-title":"Ann Lab Med"},{"issue":"S1","key":"5887_CR12","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1016\/j.pathol.2018.12.369","volume":"51","author":"D Wong","year":"2019","unstructured":"Wong D, Friebe A, Wall M et al (2019) A rare case of atypical form of chronic myeloid leukaemia with ETV6-ABL1. Pathology 51(S1):S128","journal-title":"Pathology"},{"issue":"4","key":"5887_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000448984","volume":"136","author":"N Mori","year":"2016","unstructured":"Mori N, Ohwashi-Miyazaki M, Okada M et al (2016) Translocation (9;12)(q34.1;p13.?3) resulted in ETV6-ABL1 fusion in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia. Acta Haematol 136(4):240\u2013243","journal-title":"Acta Haematol"},{"issue":"2","key":"5887_CR14","first-page":"614","volume":"106","author":"J Yao","year":"2021","unstructured":"Yao J, Xu L, Aypar U et al (2021) Myeloid\/lymphoid neoplasms with eosinophilia\/basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition. Haematologica 106(2):614\u2013618","journal-title":"Haematologica"},{"issue":"1","key":"5887_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1755-8166-6-39","volume":"6","author":"K Gancheva","year":"2013","unstructured":"Gancheva K, Virchis A, Howard-Reeves J et al (2013) Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review. Mol Cytogenet 6(1):39","journal-title":"Mol Cytogenet"},{"issue":"2","key":"5887_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","volume":"77","author":"TR Golub","year":"1994","unstructured":"Golub TR, Barker GF, Lovett M et al (1994) Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77(2):307\u2013316","journal-title":"Cell"},{"issue":"15","key":"5887_CR17","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1101\/gad.12.15.2392","volume":"12","author":"LC Wang","year":"1998","unstructured":"Wang LC, Swat W, Fujiwara Y et al (1998) The TEL\/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev 12(15):2392\u20132402","journal-title":"Genes Dev"},{"key":"5887_CR18","doi-asserted-by":"crossref","unstructured":"Hock H, Shimamura A ETV6 in hematopoiesis and leukemia predisposition. Semin Hematol 54(2):98\u2013104","DOI":"10.1053\/j.seminhematol.2017.04.005"},{"issue":"1","key":"5887_CR19","first-page":"34","volume":"55","author":"P Papadopoulos","year":"1995","unstructured":"Papadopoulos P, Ridge SA, Boucher CA et al (1995) The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res 55(1):34\u201338","journal-title":"Cancer Res"},{"issue":"10","key":"5887_CR20","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/gcc.20796","volume":"49","author":"J Zuna","year":"2010","unstructured":"Zuna J, Zaliova M, Muzikova K et al (2010) Acute leukemias with ETV6\/ABL1 (TEL\/ABL) fusion: poor prognosis and prenatal origin. Genes Chromosom Cancer 49(10):873\u2013884","journal-title":"Genes Chromosom Cancer"},{"issue":"9","key":"5887_CR21","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3324\/haematol.2016.144345","volume":"101","author":"M Zaliova","year":"2016","unstructured":"Zaliova M, Moorman AV, Cazzaniga G et al (2016) Characterization of leukemias with ETV6-ABL1 fusion. Haematologica 101(9):1082\u20131093","journal-title":"Haematologica"},{"issue":"1","key":"5887_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/ijms25010118","volume":"25","author":"MT Bochicchio","year":"2024","unstructured":"Bochicchio MT, Marconi G, Baldazzi C et al (2024) ETV6::ABL1-positive myeloid neoplasm: a case of a durable response to imatinib mesylate without additional or previous treatment. Int J Mol Sci 25(1):118","journal-title":"Int J Mol Sci"},{"issue":"8","key":"5887_CR23","first-page":"789","volume":"87","author":"R La Starza","year":"2002","unstructured":"La Starza R, Trubia M, Testoni N et al (2002) Clonal eosinophils are a morphologic hallmark of ETV6\/ABL1 positive acute myeloid leukemia. Haematologica 87(8):789\u2013794","journal-title":"Haematologica"},{"issue":"7","key":"5887_CR24","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/ajh.25825","volume":"95","author":"J Schwaab","year":"2020","unstructured":"Schwaab J, Naumann N, Luebke J et al (2020) Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes. Am J Hematol 95(7):824\u2013833","journal-title":"Am J Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05887-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05887-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05887-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T09:15:12Z","timestamp":1724836512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05887-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["5887"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05887-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2024,7,12]]},"assertion":[{"value":"9 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This clinical observation was approved by the Ethics Committee of the Zhognnan Hospital Wuhan University. The patients\/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifable images or data included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}